Daniel Rueda
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Genetic factors in colorectal cancer 20
- Oncology 11
- Colorectal Cancer Screening and Detection 8
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Manuel Guzmán (10 shared papers)Ismael Galve‐Roperh (10 shared papers)Cristina Sánchez (4 shared papers)Guillermo Velasco (3 shared papers)Teresa Gómez del Pulgar (2 shared papers)Amador Haro (2 shared papers)Alberto Martı́nez-Serrano (1 shared paper)Beatriz Navarro (1 shared paper)
- Journals
- Molecular Pharmacology (6 papers)Oncotarget (2 papers)Scientific Reports (2 papers)Clinical Genetics (2 papers)PLoS ONE (2 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Daniel Rueda
48 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 93
- Pharmacology 1.2k
- Cellular and Molecular Neuroscience 756
- Cancer Research 281
- Pathology and Forensic Medicine 277
- Toxicology 55
Countries citing papers authored by Daniel Rueda
This map shows the geographic impact of Daniel Rueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rueda more than expected).
Fields of papers citing papers by Daniel Rueda
This network shows the impact of papers produced by Daniel Rueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rueda. The network helps show where Daniel Rueda may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rueda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. | 2001 | 383 |
| 2 | 2008 | 238 | |
| 3 | 2002 | 217 | |
| 4 | 2000 | 173 | |
| 5 | 2002 | 168 | |
| 6 | 1998 | 168 | |
| 7 | 1999 | 148 | |
| 8 | 2001 | 88 | |
| 9 | 2006 | 77 | |
| 10 | 2013 | 65 | |
| 11 | 2007 | 39 | |
| 12 | 2015 | 26 | |
| 13 | 2019 | 25 | |
| 14 | 2018 | 20 | |
| 15 | 2019 | 20 | |
| 16 | 2011 | 20 | |
| 17 | 2014 | 20 | |
| 18 | 2013 | 19 | |
| 19 | 2020 | 16 | |
| 20 | Classifying early-onset colorectal cancer according to tumor location: new potential subcategories to explore. | 2015 | 14 |
About Daniel Rueda
Daniel Rueda is a scholar working on Pathology and Forensic Medicine, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 49 papers that have together received 2.1k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (20 papers), Cancer Genomics and Diagnostics (10 papers), Cannabis and Cannabinoid Research (10 papers), Colorectal Cancer Screening and Detection (8 papers), Neuroscience and Neuropharmacology Research (6 papers), Sleep and Wakefulness Research (5 papers), Pancreatic function and diabetes (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Pharmacology (1.2k citations), Cellular and Molecular Neuroscience (756 citations), Cancer Research (281 citations), Pathology and Forensic Medicine (277 citations) and Toxicology (55 citations). Daniel Rueda has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Manuel Guzmán, Ismael Galve‐Roperh, Cristina Sánchez, Guillermo Velasco, Teresa Gómez del Pulgar, Amador Haro, Alberto Martı́nez-Serrano, Beatriz Navarro, Marı́a L. de Ceballos and C. Corbacho. Their work appears in journals such as Molecular Pharmacology, Oncotarget, Scientific Reports, Clinical Genetics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.